ARTICLE | Company News
Quorum Sciences Inc. other research news
May 1, 2000 7:00 AM UTC
Quorum received a $1 million grant from the Cystic Fibrosis Foundation to develop compounds that inhibit Pseudomonas aeruginosa signaling to treat chronic lung infections in CF patients. The company s...